• OPEN AN ACCOUNT
Indian Indices
Nifty
22,419.95 -150.40
(-0.67%)
Sensex
73,730.16 -609.28
( -0.82%)
Bank Nifty
48,201.05 -293.90
( -0.61%)
Nifty IT
33,666.20 111.80
( 0.33%)
Global Indices
Nasdaq
15,927.90 316.14
(2.03%)
Dow Jones
38,239.66 153.86
(0.40%)
Hang Seng
17,651.15 366.61
(2.12%)
Nikkei 225
37,934.76 306.28
(0.81%)
Forex
USD-INR
83.32 0.01
(0.01%)
EUR-INR
89.30 0.19
(0.22%)
GBP-INR
104.10 0.39
(0.38%)
JPY-INR
0.54 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

piramal capital & housing finance ltd
Vimta Labs climbs on securing Govt grant for upgrading lab
Mar 02,2024
The facility is located at Vimta Life Sciences Facility, Genome Valley, Shameerpet, Hyderabad, Telangana.

This Grant in aid (GIA) will be used to modernise Vimta Labs' food testing capabilities, potentially enhancing their services and analysis accuracy. The project is expected to be completed by 1 March 2026.

Vimta Labs acts as a scientific and regulatory partner for various industries like food, agriculture, pharmaceuticals, and more. The company provides comprehensive services including contract research and testing throughout product development and manufacturing, clinical diagnostics for medical purposes, and environmental assessments to ensure product and process safety.

On a consolidated basis, net profit of Vimta Labs declined 1.07% to Rs 10.13 crore on 5.56% rise in net sales to Rs 81.68 crore in Q3 December 2023 over Q3 December 2022.